drugset / Trial / NCT00965913

Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch

NCT00965913

Phase 1 Completed 42 enrolled McNeil AB
RandomizedSingle-groupDouble-blindScreening

Summary

An investigation on the cumulative skin irritation potential of a newly developed 15 mg nicotine patch. Evaluation of skin irritation of a newly developed 15 mg nicotine transdermal patch.

Timeline

Start
2005-05
Primary completion
2005-05
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 15 mg Topical

Indications

No indication recorded.